Specific Antibody Deficiency — Optimed Immunology

What is Specific Antibody Deficiency?

A normal immunoglobulin panel does not necessarily mean the immune system is working properly. Some patients produce adequate total antibody but fail to mount effective antibody responses to specific bacteria — particularly Streptococcus pneumoniae, Haemophilus influenzae, and other encapsulated organisms. The result is a pattern of recurrent sinus, ear, and respiratory infections that look like ordinary infections but keep coming back.

Specific Antibody Deficiency is frequently missed because routine bloodwork shows normal IgG and IgM. Identifying it requires specifically testing the immune response to vaccination — measuring antibody levels before and after a polysaccharide vaccine to see whether the body can mount a protective response.

When to consider evaluation

Recurrent sinus or respiratory infections despite normal IgG
Persistent or chronic bronchitis requiring repeated antibiotic courses
Failure to respond adequately to vaccination
Bronchiectasis identified on imaging without other identified cause
Chronic productive cough

How it is diagnosed

Diagnosis requires vaccine response testing. The standard approach measures pre-vaccination pneumococcal antibody titers, administers an unconjugated pneumococcal polysaccharide vaccine, and re-measures titers four to eight weeks later. The pattern of response — how many serotypes the patient responds to, and the magnitude of the response — determines the diagnosis.

A complete workup typically also includes IgG subclasses, lymphocyte subset analysis, and assessment for any contributing structural disease such as chronic sinusitis or bronchiectasis.

Treatment options

Treatment depends on severity and individual circumstances. Many patients with mild Specific Antibody Deficiency are managed conservatively — with prompt treatment of infections as they occur and aggressive management of contributing factors. Some patients benefit from prophylactic antibiotics during high-risk seasons.

Patients with severe or refractory Specific Antibody Deficiency may be candidates for immunoglobulin replacement therapy. The decision is individualized and made together — taking into account infection burden, quality of life impact, and patient preference.

What to expect at your visit

A first visit typically includes a thorough infection history, review of any prior labs, and discussion of the testing plan. Vaccine response testing is performed in stages — baseline labs, vaccination, and follow-up labs — so the diagnostic process takes a few weeks. Dr. McNeil reviews each result personally and discusses findings and treatment options at follow-up.

Decision support

Choosing between IV, subcutaneous, and facilitated-subcutaneous immunoglobulin? See the full comparison: IVIG vs SCIG vs fSCIG →

Treatment pathway at Optimed Immunology

Every patient’s situation is different, but the decision logic for specific antibody deficiency generally follows these steps. This is not a script — it is a structure that gets adapted to each patient’s history, findings, and goals.

Confirm the diagnosis	Quantitative immunoglobulins (often normal), IgG subclasses, baseline pneumococcal antibody titers, and post-vaccination titers (typically after Pneumovax 23) to assess vaccine response. Diagnosis requires the right pattern of vaccine non-response.
Rule out look-alikes	Anatomic causes of recurrent infection (sinus anatomy, immotile cilia), secondary causes of immune impairment, and CVID.
First-line / supportive	Optimize sinus and pulmonary care, appropriate antibiotic stewardship for confirmed infections, and selective antibiotic prophylaxis in selected cases.
Advanced treatment options	Immunoglobulin replacement therapy in selected patients with severe recurrent infections despite optimized standard care, when criteria are met.
How Dr. McNeil chooses	Decision depends on infection burden, severity, and demonstrated vaccine response failure. Not every patient with SAD needs immunoglobulin replacement.
Monitoring & follow-up	Infection frequency, antibiotic use, response to interventions, and re-assessment of vaccine response over time.
Insurance & prior authorization	Ig replacement PA for SAD requires documented vaccine non-response, severe recurrent infection history, and failure of standard preventive care. Handled in-house.

Medically reviewed

Donald L. McNeil, MD · Board Certified in Allergy & Immunology and Internal Medicine

Last reviewed: November 2025 · Sources: AAAAI · ACAAI · Immune Deficiency Foundation · FDA prescribing information · relevant clinical guidelines

This page is provided for educational purposes and does not substitute for clinical judgment or direct medical advice. Treatment decisions are individualized based on your full history, examination, and laboratory findings. If you have an emergency, call 911.

Specific Antibody Deficiency.